Not all lung cancer patients who could benefit from crizotinib are identified by FDA-approved test
August 28, 2012 · Comments Off
Almost exactly a year ago, the FDA approved the drug crizotinib to treat these ALK+ lung cancer patients, who were likely never smokers. Informed doctors use the test called a FISH assay to check for the EML4-ALK fusion gene, and then if the test is positive, ALK+ patients benefit greatly from crizotinib.
University of Colorado Cancer Center researcher recognized in quest to eradicate lung cancer
June 8, 2012 · Comments Off
Ross Camidge, MD, PhD, recipient of Addario Lectureship Award An investigator for the University of...
Low testosterone with new lung cancer drug — if recognized, easy to fix
April 5, 2012 · Comments Off
Men experience a marked drop in their testosterone levels when taking a targeted therapy to...
Cancer survivor to test lungs at Livestrong Austin Half Marathon
February 15, 2012 · Comments Off
For lung cancer survivor Matt Ellefson, the Livestrong Austin Half Marathon is about more than...
People with specific kind of lung cancer respond to new targeted treatment
October 28, 2010 · Comments Off
A study in the New England Journal of Medicine shows more than half of patients...
UCCC offers ALK positive lung cancer clinical trial
February 19, 2010 · Comments Off
Learn more about the trial Aurora, Colo. (Feb. 19 2010) — The University of Colorado...
Bitter melon juice prevents pancreatic cancer in mouse models
February 19, 2010
NTRK1: a new oncogene and target in lung cancer
February 19, 2010
Federal Grant Broadens Cancer Trials Possibilities
April 22, 2014 · No comments
alk drug lung cancer ALL amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno biomarkers bladder cancer breast cancer cancer grants cancer research colorado Cancer Survivorship cell signaling clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma metastasis Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge screening skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Big win for personalized medicine at University of Colorado Anschutz Medical Campus! The benefits of... http://t.co/DyuEtrASgT
Do you care for a cancer patient? Are you feeling like you are running low on fuel? Come to the Filling Your Tank... http://t.co/5JPQd6hMCR
Do you care for a cancer patient? Are you feeling like you are running low on fuel? Come to the Filling Your Tank... http://t.co/DRD3EzlxVZ
It's time to Love Your Bottom! Please join our colorectal cancer experts at the Lone Tree Health Center for a... http://t.co/jn8VBzzysw
Thanks to The Denver Post for covering our Cocktails for a Cure event last week and thanks to 400 women who... http://t.co/vHZoiTAea0